Cyclin D1 expression, cell proliferation, and clonal persistence characterize primary cutaneous CD4 + small or medium T‐cell lymphoproliferative disorder
Histopathology · 2023-02 · 82 (3) · 485-494
DOI: 10.1111/his.14834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, online erschienen am 18.11.2022. Verfasst von Ilske Oschlies und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Hematopathology Section, University Hospital Schleswig-Holstein, Kiel, Germany. Hauptthemen laut MEDLINE: Cyclin D1, Lymphoma, T-Cell, Cutaneous. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: KinderkrebsInitiative Buchholz, Holm-Seppensen (KKI)..
Abstract (Originalsprache)
Aims
The aim was to gain insight into the biology of primary cutaneous CD4 + small/medium T‐cell lymphoproliferative disorder (PCSM‐LPD).
Methods
We describe the histopathological and clinical characteristics of 177 PCSM‐LPD diagnosed at our consultation centre. We performed immunohistochemical multistaining in a subset of cases ( n = 46) including PD1, Cyclin D1, and multiple markers of proliferation. We evaluated clonal T‐cell‐receptor‐(TCR) rearrangements and used tissue microdissection to analyse TCR‐clonality of PD1(+) cells.
Results
The cohort of n = 177 PCSM‐LPD included 84 males and 93 females (median age 57, range 13–85). Clinical presentation was as a solitary nodule or plaque (head and neck > trunk > extremities). Most patients were treated by local excision or steroids (96%, 69/72); relapses occurred in 12/65 (18%) of patients with follow up. Histopathology revealed the predominance of a nodular pattern (75%, 134/177) and frequent clustering of PD1(+) large cells (70%, 103/147). We detected Cyclin D1 and PD1 coexpression (>10% of PD1(+)‐cells) in 26/46 (57%), which was not associated with CCND1 breaks or amplifications . PD1(+)‐cells in PCSM‐LPDs showed a significantly higher expression of proliferation‐associated proteins compared to PD1(−)‐cells. A clonal TCR‐rearrangement was present in 176/177 (99%), with a clonal persistence in 7/8 patients at relapse including distant sites. Tissue‐microdissection revealed PD1(+)‐cells as the source of clonality, whilst PD1(−)‐cells remained polyclonal.
Conclusion
PCSM‐LPD is a clinically indolent, albeit neoplastic, disease driven by clonal expansion of PD1(+)‐cells. We demonstrate Cyclin D1‐expression associated with accelerated proliferation as a surprising new biological feature of the disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Hematopathology Section, University Hospital Schleswig-Holstein, Kiel, Germany.
- Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany.
ORCID-Profile: Ilske Oschlies, Wolfram Klapper
Förderung
- KinderkrebsInitiative Buchholz, Holm-Seppensen (KKI).
Zitieren
APA
Oschlies, I., Kock, K., Wüseke, T., Richter, J., Koch, K., Wehkamp, U., & Klapper, W. (2023). Cyclin D1 expression, cell proliferation, and clonal persistence characterize primary cutaneous CD4 + small or medium T‐cell lymphoproliferative disorder. Histopathology, 82(3), 485-494. https://doi.org/10.1111/his.14834
Vancouver
Oschlies I, Kock K, Wüseke T, Richter J, Koch K, Wehkamp U, et al. Cyclin D1 expression, cell proliferation, and clonal persistence characterize primary cutaneous CD4 + small or medium T‐cell lymphoproliferative disorder. Histopathology. 2023;82(3):485-494. doi:10.1111/his.14834
BibTeX
@article{Oschlies2023,
author = {Oschlies, Ilske and Kock, Katharina and Wüseke, Thomas and Richter, Julia and Koch, Karoline and Wehkamp, Ulrike and Klapper, Wolfram},
title = {Cyclin D1 expression, cell proliferation, and clonal persistence characterize primary cutaneous CD4 + small or medium T‐cell lymphoproliferative disorder},
journal = {Histopathology},
year = {2023},
volume = {82},
number = {3},
pages = {485--494},
doi = {10.1111/his.14834}
}
EUVIMED